Acura (ACUR) advised by Pfizer (PFE) Oxecta is commercially available, receives tiered royalties of 5-25% on net sales
Tweet
Share
E-mailGet Alerts ACUR Hot Sheet
Join SI Premium – FREE
Acura Pharma (Nasdaq: ACUR) advised by Pfizer (NYSE: PFE) Oxecta is commercially available. Receives tiered royalties of 5-25 percent on net sales.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nu Skin EVP of global sales takes medical leave
- Don T.P. Leung to resign from MetroCity Bankshares board
- WhiteFiber closes $310M convertible notes offering at 5% due 2032
Create E-mail Alert Related Categories
Corporate News, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
